In silico, in vitro, and in vivo analyses revealed that increased SLC2A2 expression promote hepatocyte differentiation, while its reduction correlates with advanced HCC stages and elevated stem cell markers. The gene discussed is SLC2A2; the disease is hepatocellular carcinoma.